1. Home
  2. LFMD vs HUMA Comparison

LFMD vs HUMA Comparison

Compare LFMD & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.71

Market Cap

190.9M

Sector

Health Care

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.68

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
HUMA
Founded
1994
2004
Country
United States
United States
Employees
384
220
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.9M
185.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LFMD
HUMA
Price
$3.71
$0.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$9.14
$9.29
AVG Volume (30 Days)
1.2M
8.0M
Earning Date
03-09-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.11
N/A
Revenue Next Year
$20.07
$731.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$0.70
52 Week High
$15.34
$2.93

Technical Indicators

Market Signals
Indicator
LFMD
HUMA
Relative Strength Index (RSI) 51.68 31.26
Support Level $3.43 N/A
Resistance Level $4.20 $1.30
Average True Range (ATR) 0.29 0.10
MACD -0.02 -0.04
Stochastic Oscillator 6.89 2.03

Price Performance

Historical Comparison
LFMD
HUMA

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: